CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter, Randomized, Controlled Phase 2 Study: Efficacy and Safety of I-131-1095 Radiotherapy in Combination With Enzalutamide in mCRPC Patients Who Are 18F-DCFPyL PSMA-avid, Chemotherapy-naïve, and Progressed on Abiraterone (ARROW )

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03939689
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:11.875475+00:00
Published At: 2025-10-14T00:00:00+00:00
Record Updated At: 2025-10-14
Results Posted At: 2025-10-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Prostate Cancer", "Castration-resistant Prostate Cancer", "Prostatic Neoplasm", "Cancer of the Prostate", "Progressive mCRPC"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-10-14"
protocolSection.identificationModule.nctId: "NCT03939689"
protocolSection.identificationModule.officialTitle: "A Multicenter, Randomized, Controlled Phase 2 Study: Efficacy and Safety of I-131-1095 Radiotherapy in Combination With Enzalutamide in mCRPC Patients Who Are 18F-DCFPyL PSMA-avid, Chemotherapy-na\u00efve, and Progressed on Abiraterone (ARROW )"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-10-14"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.